Marketing Manager at BiopharmaTrend
Contributing Author
Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.
Rare diseases sit at an uncomfortable scale: about 30 million people in the U.S., roughly >300 million worldwide. According to NIH, there are an estimated 6,000 to 8,000 rare diseases, though the exact number is continually changing as new …
Back in 2016, Ida Tin, the CEO behind the renowned period-tracking app Clue, introduced the term "FemTech" to capture the wave of startups pushing the boundaries of technology in the realm of female health. Today, the term encompasses an even …
Decentralized clinical trials (DCTs) are not a recent invention, but their adoption has accelerated as logistical complexity, geographic dispersion, and patient burden have come under scrutiny. The shift began long before the pandemic, but COVID-19 created a clear breakpoint as …
The field of fertility treatments is experiencing a surge in demand, fueled by several significant factors. A shift towards starting families at a later age, the increasing number of same-sex couples seeking assistance, and concerning studies revealing a decline in …
Nearly two decades ago, a groundbreaking discovery in the field of biomedical research emerged, known as organ-on-a-chip technology, which quickly captivated the interest of scientists across the globe. Led by a bioengineer Donald E. Ingber at Harvard University, this innovative …
Executives from the French AI drug discovery company Owkin have embarked on a new venture, launching Bioptimus, a startup dedicated to developing a large-language model (LLM) specifically for biotechnology. This initiative marks a significant leap in the application of LLM …
In the ongoing pursuit of new drugs and medical treatments, the pharmaceutical sector faces a complex task: verifying the safety and efficacy of these potential advancements. Clinical trials, long-drawn, expensive, and fraught with uncertainty, act as the proving ground for …
The field of 3D bioprinting has emerged as a remarkable technological advancement in recent years. This revolutionary technique involves the fabrication of living tissues, including blood vessels, bones, hearts, and skin, through the process of additive manufacturing, commonly known as …
Ever since the early 2000s, Artificial Intelligence (AI) has become a useful tool in various fields, from game design and speech recognition to powering driving cars and military applications. No wonder that big pharma companies are striving to keep up …
Needle-free vaccine delivery has emerged as a promising solution to overcome the challenges associated with frozen storage requirements, thereby improving access to vaccines. In this context, the Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with aVaxziPen Ltd, an …